These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 15942779

  • 21. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
    Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
    Pediatr Nephrol; 2016 Nov; 31(11):2095-101. PubMed ID: 27263020
    [Abstract] [Full Text] [Related]

  • 22. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 23. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil.
    Banerjee S, Pahari A, Sengupta J, Patnaik SK.
    Pediatr Nephrol; 2013 Jan; 28(1):93-7. PubMed ID: 22890513
    [Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 26. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

  • 27. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
    Nephrology (Carlton); 2015 Jan 30; 20(1):18-24. PubMed ID: 25312783
    [Abstract] [Full Text] [Related]

  • 28. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr 30; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 29. [Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].
    Márquez Peiró JF, Porta Oltra B, Marín Serra J.
    An Pediatr (Barc); 2008 Sep 30; 69(3):258-62. PubMed ID: 18775272
    [Abstract] [Full Text] [Related]

  • 30. C1q nephropathy and minimal change nephrotic syndrome.
    Wong CS, Fink CA, Baechle J, Harris AA, Staples AO, Brandt JR.
    Pediatr Nephrol; 2009 Apr 30; 24(4):761-7. PubMed ID: 19082635
    [Abstract] [Full Text] [Related]

  • 31. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
    Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G.
    Pediatr Nephrol; 2017 Jan 30; 32(1):181-184. PubMed ID: 27687621
    [Abstract] [Full Text] [Related]

  • 32. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug 30; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 33. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
    [Abstract] [Full Text] [Related]

  • 34. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.
    Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ.
    Pediatr Nephrol; 2008 Nov 10; 23(11):2013-20. PubMed ID: 18622632
    [Abstract] [Full Text] [Related]

  • 35. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Nephrology (Carlton); 2003 Jun 10; 8(3):105-9. PubMed ID: 15012724
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 10; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 37. Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy.
    Pesavento TE, Bay WH, Agarwal G, Hernandez RA, Hebert LA.
    Am J Kidney Dis; 2004 Mar 10; 43(3):e3-6. PubMed ID: 14981634
    [Abstract] [Full Text] [Related]

  • 38. The Value of Monitoring the Serum Concentration of Mycophenolate Mofetil in Children with Steroid-Dependent/Frequent Relapsing Nephrotic Syndrome.
    Tong K, Mao J, Fu H, Shen H, Liu A, Shu Q, Du L.
    Nephron; 2016 Mar 10; 132(4):327-34. PubMed ID: 26991496
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug 10; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 40. Interventions for minimal change disease in adults with nephrotic syndrome.
    Palmer SC, Nand K, Strippoli GF.
    Cochrane Database Syst Rev; 2008 Jan 23; 2008(1):CD001537. PubMed ID: 18253993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.